The dopamine transporter: A vigilant border control for psychostimulant action

Handbook of Experimental Pharmacology

Volumn 175, Issue , 2006, Pages 215-232

  Williams, J M ^a   Galli, A ^a  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Amphetamine; Cocaine; Dopamine transporter; Ion channel; Trafficking

Indexed keywords

AMPHETAMINE; COCAINE; DOPAMINE; DOPAMINE 2 RECEPTOR; DOPAMINE RECEPTOR STIMULATING AGENT; DOPAMINE TRANSPORTER; PSYCHOTROPIC AGENT;

ANIMAL; BRAIN; CHEMISTRY; DRUG EFFECT; HUMAN; METABOLISM; NERVE CELL; PROTEIN CONFORMATION; REVIEW; SYNAPTIC TRANSMISSION; SYNAPTOSOME;

AMPHETAMINE; ANIMALS; BRAIN; COCAINE; DOPAMINE; DOPAMINE AGENTS; DOPAMINE PLASMA MEMBRANE TRANSPORT PROTEINS; HUMANS; NEURONS; PRESYNAPTIC TERMINALS; PROTEIN CONFORMATION; PSYCHOTROPIC DRUGS; RECEPTORS, DOPAMINE D2; SYNAPTIC TRANSMISSION;

EID: 34548723459     PISSN: 01712004     EISSN: 18650325     Source Type: Book Series    
DOI: 10.1007/3-540-29784-7_11     Document Type: Article

References (107)

1. AlburgesME,Narang N,Wamsley JK(1993) Alterations inthe dopaminergic receptor system after chronic administration of cocaine. Synapse 14:314-323
2. Amara SG, Kuhar MJ (1993) Neurotransmitter transporters: recent progress. Annu Rev Neurosci 16:73-93
3. Amara SG, SondersMS, Zahniser NR, Povlock SL, DanielsGM(1998)Molecular physiology and regulation of catecholamine transporters. Adv Pharmacol 42:164-168
4. Amit Z, Smith BR (1992) Remoxipride, a specific D2 dopamine antagonist: an examination of its self-administration liability and its effects on d-amphetamine self-administration. Pharmacol Biochem Behav 41:259-261
5. Asher IM, Aghajanian GK (1974) 6-Hydroxydopamine lesions of olfactory tubercles and caudate nuclei: effect on amphetamine-induced stereotyped behavior in rats. Brain Res 82:1-12
6. Batchelor M, Schenk JO (1998) Protein kinase A activity may kinetically upregulate the striatal transporter for dopamine. J Neurosci 18:10304-10309
7. Beckman ML, QuickMW(1998) Neurotransmitter transporters: regulators of function and functional regulation. J Membr Biol 164:1-10
8. Benoit-Marand M,Borrelli E,Gonon F (2001) Inhibition of dopamine release via presynaptic D2 receptors: time course and functional characteristics in vivo. JNeurosci 21:9134-9141
9. Blakely RD, Bauman AL (2000) Biogenic amine transporters: regulation in flux. Curr Opin Neurobiol 10:328-336
10. Breese GR, Traylor TD (1970) Effect of 6-hydroxydopamine on brain norepinephrine and dopamine: Evidence for selective degeneration of catecholamine neurons. J Pharmacol Exp Ther 174:413-420
11. CarlezonWAJr, DevineDP,WiseRA(1995)Habit-forming actions of nomifensine in nucleus accumbens. Psychopharmacology (Berl) 122:194-197
12. Carvelli L,McDonald PW, Blakely RD, Defelice LJ (2004) Dopamine transporters depolarize neurons by a channel mechanism. Proc Natl Acad Sci U S A 101:16046-16051
13. Cass WA, Gerhardt GA (1994) Direct in vivo evidence that D2 dopamine receptors can modulate dopamine uptake. Neurosci Lett 176:259-263
14. Chi L, Reith ME (2003) Substrate-induced trafficking of the dopamine transporter in heterologously expressing cells and in rat striatal synaptosomal preparations. J Pharmacol Exp Ther 307:729-736
15. ClarkD, Furmidge LJ, Petry N, Tong ZY, Ericsson M, JohnsonD(1991) Behavioural profile of partialD2dopamine receptor agonists. 1.Atypical inhibitionofd-amphetamine-induced locomotor hyperactivity and stereotypy. Psychopharmacology (Berl) 105:381-392
16. Creese I, Iversen SD(1974) The role of forebrain dopamine systems in amphetamine induced stereotyped behavior in the rat. Psychopharmacologia 39:345-357
17. Dackis CA, OBrien CP (2001) Cocaine dependence: a disease of the brains reward centers. J Subst Abuse Treat 21:111-117
18. DavisWM, Smith SG (1973) Blocking effect of alpha-methyltyrosine on amphetamine based reinforcement. J Pharm Pharmacol 25:174-177
19. Daws LC, CallaghanPD,Moron JA,KahligKM, ShippenbergTS, Javitch JA, GalliA(2002)Cocaine increases dopamine uptake and cell surface expression of dopamine transporters. Biochem Biophys Res Commun 290:1545-1550
20. de la Garza R, Johanson CE (1982) Effects of haloperidol and physostigmine on selfadministration of local anesthetics. Pharmacol Biochem Behav 17:1295-1299
21. DeFelice LJ, Galli A (1998) Electrophysiological analysis of transporter function. Adv Pharmacol 42:186-190
22. Deutch AY, Goldstein M, Baldino F Jr, Roth RH (1988) Telencephalic projections of the A8 dopamine cell group. Ann N Y Acad Sci 537:27-50
23. Dickinson SD, Sabeti J, Larson GA, Giardina K, Rubinstein M, Kelly MA, Grandy DK, LowMJ, Gerhardt GA, Zahniser NR (1999) Dopamine D2 receptor-deficientmice exhibit decreased dopamine transporter function but no changes in dopamine release in dorsal striatum. J Neurochem 72:148-156
24. Fibiger HC, Zis AP, McGeer EG (1973) Feeding and drinking deficits after 6-hydroxydopamine administration in the rat: similarities to the lateral hypothalamic syndrome. Brain Res 55:135-148
25. Fischer J, Cho A (1979) Chemical release of dopamine from striatal homogenates: evidence for an exchange diffusion model. J Pharmacol Exp Ther 208:203-209
26. Fleckenstein AE, Metzger RR, Wilkins DG, Gibb JW, Hanson GR (1997) Rapid and reversible effects of methamphetamine on dopamine transporters. J Pharmacol Exp Ther 282:834-838
27. Fleckenstein AE, Haughey HM, Metzger RR, Kokoshka JM, Riddle EL, Hanson JE, Gibb JW, Hanson GR (1999) Differential effects of psychostimulants and related agents on dopaminergic and serotonergic transporter function. Eur J Pharmacol 382:45-49
28. Furmidge LJ, Exner M, Clark D (1991) Role of dopamine D1 and D2 receptors in mediating the d-amphetamine discriminative cue. Eur J Pharmacol 202:191-199
29. Gainetdinov RR, Sotnikova TD, Caron MG (2002) Monoamine transporter pharmacology and mutant mice. Trends Pharmacol Sci 23:367-373
30. Galli A, Blakely RD, DeFelice LJ (1998) Patch-clamp and amperometric recordings from norepinephrine transporters: channel activity and voltage-dependent uptake. Proc Natl Acad Sci U S A 95:13260-13265
31. Giros B, Caron MG (1993) Molecular characterization of the dopamine transporter. Trends Pharmacol Sci 14:43-49
32. Giros B, el Mestikawy S, Bertrand L, Caron MG (1991) Cloning and functional characterization of a cocaine-sensitive dopamine transporter. FEBS Lett 295:149-154
33. Giros B, el Mestikawy S, Godinot N, Zheng K, Han H, Yang-Feng T, Caron MG (1992) Cloning, pharmacological characterization, and chromosome assignment of the human dopamine transporter. Mol Pharmacol 42:383-390
34. Giros B, Jaber M, Jones SR, Wightman RM, Caron MG (1996) Hyperlocomotion and indifference to cocaine and amphetamine in mice lacking the dopamine transporter. Nature 379:606-612
35. Glowinski J, Axelrod J, Iversen LL (1966) Regional studies of catecholamines in the rat brain. IV. Effects of drugs on the disposition and metabolism of H3-norepinephrine and H3-dopamine. J Pharmacol Exp Ther 153:30-41
36. Gnegy ME, Khoshbouei H, Berg KA, Javitch JA, Clarke WP, Zhang M, Galli A (2004) Intracellular Ca2+ regulates amphetamine-induced dopamine efflux and currents mediated by the human dopamine transporter. Mol Pharmacol 66:137-143
37. Gu H, Wall SC, Rudnick G (1994) Stable expression of biogenic amine transporters reveals differences in inhibitor sensitivity, kinetics, and ion dependence. J Biol Chem 269:7124-7130
38. Gulley JM, Zahniser NR (2003) Rapid regulation of dopamine transporter function by substrates, blockers and presynaptic receptor ligands. Eur J Pharmacol 479:139-152
39. Gulley JM, Doolen S, Zahniser NR (2002) Brief, repeated exposure to substrates downregulates dopamine transporter function in Xenopus oocytes in vitro and rat dorsal striatum in vivo. J Neurochem 83:400-411
40. HeikkilaR, OrlanskyH,CohenG(1975) Studies onthe distinctionbetweenuptake inhibition and release of [3H]dopamine in rat brain tissue slices. Biochem Pharmacol 24:847-852
41. Hertting G,AxelrodJ (1961)Fateof tritiatednoradrenaline at the sympathetic nerve endings. Nature 192:172-173
42. Ingram SL, Prasad BM, Amara SG (2002) Dopamine transporter-mediated conductances increase excitability of midbrain dopamine neurons. Nat Neurosci 5:971-978
43. Jardetzky O (1966) Simple allosteric model for membrane pumps. Nature 211:969-970
44. Jayanthi LD,ApparsundaramS,MaloneMD,WardE,MillerDM,EpplerM, BlakelyRD(1998) The Caenorhabditis elegans gene T23G5.5 encodes an antidepressant- and cocainesensitive dopamine transporter. Mol Pharmacol 54:601-609
45. Jones SR, Joseph JD, Barak LS, Caron MG, Wightman RM (1999) Dopamine neuronal transport kinetics and effects of amphetamine. J Neurochem 73:2406-2414
46. Kahlig KM, Galli A (2003) Regulation of dopamine transporter function and plasma membrane expressionby dopamine,amphetamine, and cocaine.Eur J Pharmacol 479:153-158
47. Kahlig KM, Javitch JA, Galli A (2004) Amphetamine regulation of dopamine transport. Combined measurements of transporter currents and transporter imaging support the endocytosis of an active carrier. J Biol Chem 279:8966-8975
48. Kahlig KM, Binda F, Khoshbouei H, Blakely RD, McMahon DG, Javitch JA, Galli A (2005) Amphetamine induces dopamine efflux through a dopamine transporter channel. Proc Natl Acad Sci U S A 102:3495-3500
49. Kantor L,Hewlett GH, Park YH, Richardson-Burns SM,MellonMJ,GnegyME (2001) Protein kinase C and intracellular calcium are required for amphetamine-mediated dopamine release via the norepinephrine transporter in undifferentiated PC12 cells. J Pharmacol Exp Ther 297:1016-1024
50. Kelly P, Seviour P, Iversen S (1975) Amphetamine and apomorphine responses in the rat following 6-OHDA lesions of the nucleus accumbens septi and corpus striatum. Brain Res 94:507-522
51. Khoshbouei H, Wang H, Lechleiter JD, Javitch JA, Galli A (2003) Amphetamine-induced dopamine efflux.Avoltage-sensitive and intracellularNa+- dependentmechanism. J Biol Chem 278:12070-12077
52. Khoshbouei H, Sen N, Guptaroy B, Johnson L, Lund D, GnegyME, Galli A, Javitch JA (2004) N-terminal phosphorylation of the dopamine transporter is required for amphetamineinduced efflux. PLoS Biol 2:E78
53. Kilty JE, Lorang D, Amara SG (1991) Cloning and expression of a cocaine-sensitive rat dopamine transporter. Science 254:578-579
54. Kim S,Westphalen R, Callahan B, Hatzidimitriou G, Yuan J, Ricaurte GA (2000) Toward development of an in vitro model of methamphetamine-induced dopamine nerve terminal toxicity. J Pharmacol Exp Ther 293:625-633
55. Kimmel HL, JoyceAR, Carroll FI,Kuhar MJ (2001) Dopamine D1 and D2 receptors influence dopamine transporter synthesis and degradation in the rat. J Pharmacol Exp Ther 298:129-140
56. Kokoshka JM, Vaughan RA, Hanson GR, Fleckenstein AE (1998) Nature of methamphetamine- induced rapid and reversible changes in dopamine transporters. Eur J Pharmacol 361:269-275
57. Koob GF (1992) Drugs of abuse: anatomy, pharmacology and function of reward pathways. Trends Pharmacol Sci 13:177-184
58. Koob GF, BloomFE (1988) Cellular and molecular mechanisms of drug dependence. Science 242:715-723
59. KruegerBK(1990) Kinetics and block of dopamine uptake in synaptosomes fromrat caudate nucleus. J Neurochem 55:260-267
60. Kuhar MJ, Ritz MC, Boja JW (1991) The dopamine hypothesis of the reinforcing properties of cocaine. Trends Neurosci 14:299-302
61. Langer SZ (1997) 25 years since the discovery of presynaptic receptors: present knowledge and future perspectives. Trends Pharmacol Sci 18:95-99
62. Le Moal M, Simon H (1991) Mesocorticolimbic dopaminergic network: functional and regulatory roles. Physiol Rev 71:155-234
63. Lester HA,Mager S, QuickMW, Corey JL (1994) Permeation properties of neurotransmitter transporters. Annu Rev Pharmacol Toxicol 34:219-249
64. Lester HA, Cao Y, Mager S (1996) Listening to neurotransmitter transporters. Neuron 17:807-810
65. Little KY, Kirkman JA, Carroll FI, Clark TB, Duncan GE (1993) Cocaine use increases [3H]WIN35428 binding sites in human striatum. Brain Res 628:17-25
66. Little KY, Elmer LW, Zhong H, Scheys JO, Zhang L (2002) Cocaine induction of dopamine transporter trafficking to the plasma membrane. Mol Pharmacol 61:436-445
67. Lorrain DS, Arnold GM, Vezina P (1999) Mesoaccumbens dopamine and the self-administration of amphetamine. Ann N Y Acad Sci 877:820-822
68. Lynch MR, Wise RA (1985) Relative effectiveness of pimozide, haloperidol and trifluoperazine onself-stimulationrate-intensity functions. PharmacolBiochemBehav 23:777-780
69. Lyness WH, Friedle NM,Moore KE (1979) Destruction of dopaminergic nerve terminals in nucleus accumbens: effect on d-amphetamine self-administration. Pharmacol Biochem Behav 11:553-556
70. Mash DC, Pablo J, Ouyang Q, HearnWL, Izenwasser S (2002) Dopamine transport function is elevated in cocaine users. J Neurochem 81:292-300
71. Mayfield RD, Zahniser NR (2001) Dopamine D2 receptor regulation of the dopamine transporter expressed in Xenopus laevis oocytes is voltage-independent. Mol Pharmacol 59:113-121
72. Meiergerd SM, Patterson TA, Schenk JO (1993) D2 receptors may modulate the function of the striatal transporter for dopamine: kinetic evidence fromstudies in vitro and in vivo. J Neurochem 61:764-767
73. Melikian HE (2004) Neurotransmitter transporter trafficking: endocytosis, recycling, and regulation. Pharmacol Ther 104:17-27
74. Metzger RR, Hanson GR, Gibb JW, Fleckenstein AE (1998) 3-4-Methylenedioxymethamphetamine- induced acute changes in dopamine transporter function. Eur J Pharmacol 349:205-210
75. Mortensen OV, Amara SG (2003) Dynamic regulation of the dopamine transporter. Eur J Pharmacol 479:159-170
76. Oades RD, Halliday GM (1987) Ventral tegmental (A10) system: neurobiology. 1. Anatomy and connectivity. Brain Res 434:117-165
77. Parsons LH, Schad CA, Justice JB Jr (1993) Co-administration of theD2 antagonist pimozide inhibits up-regulation of dopamine release and uptake induced by repeated cocaine. J Neurochem 60:376-379
78. Pettit HO, Ettenberg A, Bloom FE, Koob GF (1984) Destruction of dopamine in the nucleus accumbens selectively attenuates cocaine but not heroin self-administration in rats. Psychopharmacology (Berl) 84:167-173
79. Pierce RC, Kalivas PW (1997) Repeated cocaine modifies the mechanism by which amphetamine releases dopamine. J Neurosci 17:3254-3261
80. Porzgen P, Park SK, Hirsh J, Sonders MS, Amara SG (2001) The antidepressant-sensitive dopamine transporter in Drosophila melanogaster: a primordial carrier for catecholamines. Mol Pharmacol 59:83-95
81. Prasad BM, Amara SG (2001) The dopamine transporter in mesencephalic cultures is refractory to physiological changes in membrane voltage. J Neurosci 21:7561-7567
82. Ramamoorthy S, Giovanetti E, Qian Y, Blakely RD (1998) Phosphorylation and regulation of antidepressant-sensitive serotonin transporters. J Biol Chem 273:2458-2466
83. Ritz MC, Lamb RJ, Goldberg SR, Kuhar MJ (1987) Cocaine receptors on dopamine transporters are related to self-administration of cocaine. Science 237:1219-1223
84. Roberts DC, Corcoran ME, Fibiger HC (1977) On the role of ascending catecholaminergic systems in intravenous self-administration of cocaine. Pharmacol Biochem Behav 6:615-620
85. Sandoval V, Riddle EL, Ugarte YV, Hanson GR, Fleckenstein AE (2001)Methamphetamineinduced rapid and reversible changes in dopamine transporter function: an in vitro model. J Neurosci 21:1413-1419
86. Saunders C, Ferrer JV, Shi L, Chen J, Merrill G, Lamb ME, Leeb-Lundberg LM, Carvelli L, Javitch JA, Galli A (2000) Amphetamine-induced loss of human dopamine transporter activity: an internalization-dependent and cocaine-sensitivemechanism. ProcNatlAcad Sci U S A 97:6850-6855
87. Schmitz Y, Benoit-Marand M, Gonon F, Sulzer D (2003) Presynaptic regulation of dopaminergic neurotransmission. J Neurochem 87:273-289
88. Seidel S, Singer EA, Just H, Farhan H, Scholze P, KudlacekO,Holy M, Koppatz K, Krivanek P, Freissmuth M, Sitte HH (2005) Amphetamines take two to tango: an oligomer-based counter-transport model of neurotransmitter transport explores the amphetamine action. Mol Pharmacol 67:140-151
89. Shimada S, Kitayama S, Lin CL, Patel A, Nanthakumar E, Gregor P, Kuhar M, Uhl G (1991) Cloning and expression of a cocaine-sensitive dopamine transporter complementary DNA. Science 254:576-578
90. Sitte HH, Huck S, Reither H, Boehm S, Singer EA, Pifl C (1998) Carrier-mediated release, transport rates, and charge transfer induced by amphetamine, tyramine, and dopamine in mammalian cells transfected with the human dopamine transporter. J Neurochem 71:1289-1297
91. Sonders MS, Amara SG (1996) Channels in transporters. Curr Opin Neurobiol 6:294-302
92. SondersMS, Zhu SJ, Zahniser NR, KavanaughMP, Amara SG (1997)Multiple ionic conductances of the human dopamine transporter: the actions of dopamine and psychostimulants. J Neurosci 17:960-974
93. Staley JK, Hearn WL, Ruttenber AJ,Wetli CV, Mash DC (1994) High affinity cocaine recognition sites on the dopamine transporter are elevated in fatal cocaine overdose victims. J Pharmacol Exp Ther 271:1678-1685
94. Sulzer D, Galli A (2003) Dopamine transport currents are promoted from curiosity to physiology. Trends Neurosci 26:173-176
95. Sulzer D, Rayport S (1990) Amphetamine and other psychostimulants reduce pH gradients in midbrain dopaminergic neurons and chromaffin granules: a mechanism of action. Neuron 5:797-808
96. Sulzer D, Pothos E, Sung HM,Maidment NT, Hoebel BG, Rayport S (1992)Weak base model of amphetamine action. Ann N Y Acad Sci 654:525-528
97. Sulzer D, Chen TK, Lau YY, Kristensen H, Rayport S, Ewing A (1995) Amphetamine redistributes dopamine fromsynaptic vesicles to the cytosol and promotes reverse transport. J Neurosci 15:4102-4108
98. Sulzer D, SondersMS, PoulsenNW, Galli A (2005)Mechanisms of neurotransmitter release by amphetamines: a review. Prog Neurobiol 75:406-433
99. ThompsonTL,Bridges SR,WeirsWJ (2001) Alterationofdopamine transport inthe striatum and nucleus accumbens of ovariectomized and estrogen-primed rats following N-(pisothiocyanatophenethyl) spiperone (NIPS) treatment. Brain Res Bull 54:631-638
100. Torres GE, Gainetdinov RR, CaronMG(2003) Plasma membrane monoamine transporters: structure, regulation and function. Nat Rev Neurosci 4:13-25
101. Uhl GR, Hall FS, Sora I (2002) Cocaine, reward, movement and monoamine transporters. Mol Psychiatry 7:21-26
102. Usdin TB, Mezey E, Chen C, Brownstein MJ, Hoffman BJ (1991) Cloning of the cocainesensitive bovine dopamine transporter. Proc Natl Acad Sci U S A 88:11168-11171
103. Wilson JM, Nobrega JN, CarrollME, NiznikHB, ShannakK, Lac ST, PristupaZB,Dixon LM, Kish SJ (1994) Heterogeneous subregional binding patterns of 3H-WIN35428 and 3HGBR12935 are differentially regulated by chronic cocaine self-administration. J Neurosci 14:2966-2979
104. Wise RA (2002) Brain reward circuitry: insights from unsensed incentives. Neuron 36:229-240
105. Wu X, Gu HH (1999) Molecular cloning of the mouse dopamine transporter and pharmacological comparison with the human homologue. Gene 233:163-170
106. Yokel RA,Wise RA (1975) Increased lever pressing for amphetamine after pimozide in rats: implications for a dopamine theory of reward. Science 187:547-549
107. Zahniser NR, Doolen S (2001) Chronic and acute regulation of Na+/Cl?-dependent neurotransmitter transporters: drugs, substrates, presynaptic receptors, and signaling systems. Pharmacol Ther 92:21-55